Prudential Financial Inc Eq Rx, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.66 - $2.31 $257,549 - $358,396	-155,150 Reduced 87.17%	22,835 $50,000
Q2 2023 Aug 11, 2023	BUY	$1.61 - $1.96 $263,138 - $320,342	163,440 Added 1123.69%	177,985 $331,000
Q1 2023 May 12, 2023	SELL	$1.8 - $2.83 $234 - $367	-130 Reduced 0.89%	14,545 $28,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $184 - $495	90 Added 0.62%	14,675 $0
Q3 2022 Nov 04, 2022	BUY	$0.94 - $5.99 $3,181 - $20,276	3,385 Added 30.22%	14,585 $72,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $35,840 - $63,728	11,200 New	11,200 $53,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.